SMi’s 10th Annual RNA Therapeutics Returns to London this February 2019!

On Sep 26, 2018

SMi Group announces the 10^th Annual RNA Therapeutics Conference in London on February 20th – 21st 2019. Undoubtedly, the field of RNA therapeutics is currently undergoing a major expansion, and the potential for using RNA drugs for personalised medicines and immunotherapy, as well as to address genetic, infectious and chronic diseases will ensure the continued development of RNA therapeutics for years to come.

Fulfilling the potential of genetic discoveries requires the development of therapeutics that can specifically modulate the expression of disease-relevant genes. RNA-based drugs, including siRNAs and antisense nucleotides, are promising examples of a newer class of biologics. Researchers have tried to overcome the major challenges for utilising RNAs in a therapeutic context, including: intracellular delivery, stability and immunogenicity.

Join us in February 2019, for SMi’s 10^th annual sell out conference, RNA Therapeutics. Bringing together industry experts from leading RNA companies, to discuss the challenges for clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies, and present an overview of the applications of RNA-based drugs for modulation of gene and protein expression, and genome editing.

Network and learn from key opinion leaders such as:

Chair’s for 2019:

Ekkehard Leberer, Senior Director, Alliance Management, Sanofi
Shalini Andersson, Senior Director and Head of New Modalities, AstraZeneca

Keynote Speakers:

Carsten Rudolf, Chief Executive Officer, Ethris Gmbh
Paul Agris, Founder and Director, The RNA Institute
Marian Gindy, Executive Director, Pharmaceutical Sciences, Merck Research Labs, Merck & Co, inc.
David Giljohan, CEO, Exicure
Ingmar Hoerr, Founder & CEO, CureVac AG
David Blakey, Chief Scientific Officer, MiNA Therapeutics
André Gerber, Professor of RNA Biology, University of Surrey
Heinrich Haas, Vice President Drug Delivery, BioNTech RNA Pharmaceuticals
Markus Mandler, Chief Scientific Officer, Accanis Biotech
Troels Koch, Vice President & Head of Research, RNA Therapeutics, Roche
Hans Kistemaker, Associate Director, ProQR

2019 Featured Highlights:

Discover the clinical progress of Spherical Nucleic Acids at Exicure
Understand Sanofi’s strategies to deliver therapeutic oligonucleotides across biobarriers
Learn from ProQR how to plan for oligonucleotide supply from personalized medicine to large scale markets
Explore the development of small activating RNA – from bench to bedside with MiNA Therapeutics
Gain insight into the discovery and development of self-amplifying mRNA vaccines at GSK

Download a value-packed brochure online: www.therapeutics-rna.com/prpj

Here’s a few of last year’s attendees:

Download the full attendee list in the download centre and brochure online: www.therapeutics-rna.com/prpj

For those looking to attend, there is currently a £400 early-bird saving, only valid online. Register today

Follow ‘SMi Pharma’ on LinkedIn for latest pharmaceutical industry updates.

SMi Presents the 10^th annual conference:
RNA Therapeutics
Date: 20^th – 21^st February 2019
Location: Copthorne Tara Hotel, London UK
Website: www.therapeutics-rna.com/prpj

Contact Information:

For all media inquiries contact Pav Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk